Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 109 M106 M105 M114 M99 M 424 M Research & development 13 M11 M8 M10 M9 M 38 M Operating income 18 M7 M58 M-306 M-53 M -294 M Non-Operating Income, Total -1 M-8 M-6 M11 M-4 M -7 M Interest expense, net of interest capitalized 81 M85 M91 M84 M79 M 339 M Non-Operating Income, excl. Interest Expenses -81 M-88 M-95 M-84 M-78 M -345 M Unusual income/expense -1 M-5 M-2 M11 M-5 M -1 M Pretax income 209 M225 M235 M-718 M142 M -116 M Equity in earnings 23 M28 M31 M37 M26 M 122 M Taxes 30 M6 M21 M-3 M18 M 42 M Non-controlling/minority interest 4 M6 M7 M9 M2 M 24 M After tax other income/expense ————— — Net income before discontinued operations -16 M-5 M30 M-138 M-73 M -186 M Discontinued operations ————— — Net income -16 M-5 M30 M-138 M-73 M -186 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -16 M-5 M30 M-138 M-73 M -186 M Basic earnings per share (Basic EPS) -0.1-0.030.19-0.9-0.48 -1.22 Diluted earnings per share (Diluted EPS) -0.1-0.030.19-0.9-0.48 -1.22 Average basic shares outstanding 153.71 M153.99 M153.57 M153.55 M152.68 M — Diluted shares outstanding 153.71 M153.99 M155.22 M153.55 M152.68 M — EBITDA 191 M185 M240 M11 M116 M 552 M EBIT 76 M67 M120 M-115 M0 72 M Cost of revenue 1.29 B1.41 B1.35 B1.27 B1.34 B 5.37 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 115 M118 M120 M126 M116 M 480 M